SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 469 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $943,654 | +3.1% | 4,448 | -6.4% | 0.01% | +25.0% |
| Q2 2023 | $914,960 | -36.1% | 4,754 | -32.8% | 0.00% | -42.9% |
| Q1 2023 | $1,432,685 | +34.6% | 7,076 | -14.6% | 0.01% | +40.0% |
| Q4 2022 | $1,064,204 | -26.8% | 8,281 | -22.1% | 0.01% | -37.5% |
| Q3 2022 | $1,454,000 | -34.6% | 10,628 | -15.4% | 0.01% | -27.3% |
| Q2 2022 | $2,224,000 | -22.2% | 12,570 | -36.6% | 0.01% | -8.3% |
| Q1 2022 | $2,857,000 | -55.4% | 19,833 | -52.1% | 0.01% | -53.8% |
| Q4 2021 | $6,399,000 | -58.6% | 41,391 | -54.5% | 0.03% | -61.2% |
| Q3 2021 | $15,450,000 | +16.0% | 90,989 | +7.9% | 0.07% | +15.5% |
| Q2 2021 | $13,317,000 | -36.7% | 84,351 | -44.3% | 0.06% | +18.4% |
| Q1 2021 | $21,024,000 | +343.2% | 151,394 | +458.9% | 0.05% | +113.0% |
| Q4 2020 | $4,744,000 | – | 27,089 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |